As of January 23, 2025, Theravet SA (ALVET.PA) has a market cap of $13.743 million USD. According to our data, Theravet SA is ranked No.8746 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $13.74 M |
2.86%
|
Dec 31, 2024 | $13.36 M |
-92.76%
|
Dec 29, 2023 | $0.18 B |
-42.00%
|
Dec 30, 2022 | $0.32 B |
-56.14%
|
Dec 31, 2021 | $0.73 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Zoetis
ZTS
|
$75.18 B |
-0.001 M
|
USA
|
Elanco
ELAN
|
$5.98 B |
0.000 M
|
USA
|
IDEXX Laboratories
IDXX
|
$35.26 B |
-0.002 M
|
USA
|
Virbac SA
VIRP.PA
|
$2.70 B |
-0.000 M
|
France
|
Phibro Animal Health
PAHC
|
$0.88 B |
0.439 B
|
USA
|
Vetoquinol
VETO.PA
|
$0.83 B |
8.608 M
|
France
|
PetIQ
PETQ
|
$0.93 B |
0.000 M
|
USA
|
Neogen
NEOG
|
$2.59 B |
0.000 M
|
USA
|
Zomedica Pharmaceuticals
ZOM
|
$0.12 B |
0.000 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Market Cap | = | ALVET.PA Stock Price | * | ALVET.PA Shares Outstanding |
= | $0.11 | * | 0.12 B | |
= | $13.74 M |